Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma

Expression of interleukin-23 receptor (IL-23R) and IL-17 in urinary bladder carcinoma (UBC) was investigated to explore the correlations with prognosis. IL-23/IL-17 axis significantly inhibited the development of inflammatory bowel disease. Thirty patients with UBC were enrolled in Zhengzhou Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian, Wang, Lei, Wang, Tongqing, Wang, Jizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126236/
https://www.ncbi.nlm.nih.gov/pubmed/30214568
http://dx.doi.org/10.3892/ol.2018.9145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126236/
https://www.ncbi.nlm.nih.gov/pubmed/30214568
http://dx.doi.org/10.3892/ol.2018.9145

Ejemplares similares